JNK Activation Correlates with Cognitive Impairment and Alteration of the Post-Synaptic Element in the 5xFAD AD Mouse Model.
c-Jun N-terminal kinase
cell death
cognitive decline
synaptic dysfunction
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
15 03 2023
15 03 2023
Historique:
received:
15
02
2023
revised:
10
03
2023
accepted:
12
03
2023
medline:
30
3
2023
entrez:
29
3
2023
pubmed:
30
3
2023
Statut:
epublish
Résumé
The c-Jun N-terminal kinases (JNKs) are a family of proteins that, once activated by stress stimuli, can alter neuronal functions and survival. The JNK cascade plays a crucial role in the post-synaptic neuronal compartment by altering its structural organization and leading, at worst, to an overall impairment of neuronal communication. Increasing evidence suggests that synaptic impairment is the first neurodegenerative event in Alzheimer's disease (AD). To better elucidate this mechanism, we longitudinally studied 5xFAD mice at three selected time points representative of human AD symptom progression. We tested the mice cognitive performance by using the radial arm water maze (RAWM) in parallel with biochemical evaluations of post-synaptic enriched protein fraction and total cortical parenchyma. We found that 5xFAD mice presented a strong JNK activation at 3.5 months of age in the post-synaptic enriched protein fraction. This JNK activation correlates with a structural alteration of the post-synaptic density area and with memory impairment at this early stage of the disease that progressively declines to cause cell death. These findings pave the way for future studies on JNK as a key player in early neurodegeneration and as an important therapeutic target for the development of new compounds able to tackle synaptic impairment in the early phase of AD pathology.
Identifiants
pubmed: 36980245
pii: cells12060904
doi: 10.3390/cells12060904
pmc: PMC10047857
pii:
doi:
Substances chimiques
JNK Mitogen-Activated Protein Kinases
EC 2.7.11.24
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/S00324X/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/M006298/1
Pays : United Kingdom
Références
Biol Psychiatry. 2015 Nov 15;78(10):702-10
pubmed: 26003861
Nat Rev Neurosci. 2014 May;15(5):285-99
pubmed: 24739785
Neuron. 2007 Nov 8;56(3):488-502
pubmed: 17988632
Mol Cell Neurosci. 2012 Mar;49(3):300-10
pubmed: 22206897
Nat Med. 2003 Sep;9(9):1180-6
pubmed: 12937412
Nat Protoc. 2006;1(4):1671-9
pubmed: 17487150
Nat Med. 2017 Sep 8;23(9):1018-1027
pubmed: 28886007
J Mol Cell Biol. 2013 Aug;5(4):277-9
pubmed: 23606726
Cold Spring Harb Perspect Med. 2012 Jul;2(7):a006338
pubmed: 22762015
Pharmacol Res. 2020 Oct;160:105090
pubmed: 32707231
J Neurochem. 2001 Jan;76(2):435-41
pubmed: 11208906
J Biol Chem. 2002 Feb 1;277(5):3767-75
pubmed: 11724784
Redox Biol. 2020 Oct;37:101712
pubmed: 32949970
Neural Regen Res. 2023 Mar;18(3):531-532
pubmed: 36018163
Front Pharmacol. 2016 Jan 12;6:321
pubmed: 26793112
Sci Data. 2021 Oct 15;8(1):270
pubmed: 34654824
Antioxid Redox Signal. 2016 Dec 1;25(16):886-901
pubmed: 27392670
CNS Neurol Disord Drug Targets. 2010 Apr;9(2):156-67
pubmed: 20205644
J Alzheimers Dis. 2011;26(2):315-29
pubmed: 21628793
eNeuro. 2020 Feb 20;7(1):
pubmed: 31937523
FEBS Lett. 1997 Jun 2;409(1):57-62
pubmed: 9199504
Age (Dordr). 2007 Sep;29(2-3):87-96
pubmed: 19424834
Hum Genet. 2013 Apr;132(4):461-71
pubmed: 23329067
J Biol Chem. 2002 Nov 1;277(44):42060-5
pubmed: 12191990
Neurobiol Aging. 1999 Nov-Dec;20(6):581-9
pubmed: 10674423
BMC Biol. 2021 Dec 16;19(1):256
pubmed: 34911542
J Biol Chem. 2011 Dec 23;286(51):43871-43880
pubmed: 22033930
Neurobiol Aging. 2012 Jan;33(1):196.e29-40
pubmed: 20619937
Free Radic Biol Med. 2008 Jun 15;44(12):2051-7
pubmed: 18423383
Neurobiol Dis. 2020 Jul;140:104812
pubmed: 32087286
J Cell Biol. 2003 Oct 13;163(1):83-95
pubmed: 14557249
ASN Neuro. 2021 Jan-Dec;13:1759091420981206
pubmed: 33601918
Neuroscience. 2018 Nov 21;393:196-205
pubmed: 30315879
Lancet Neurol. 2015 Apr;14(4):388-405
pubmed: 25792098
Neurobiol Dis. 2009 Feb;33(2):229-35
pubmed: 19026746
J Alzheimers Dis. 2021;82(s1):S127-S139
pubmed: 33216036
Cells. 2020 Feb 14;9(2):
pubmed: 32074971
Neurodegener Dis. 2007;4(1):13-27
pubmed: 17429215
J Neurosci. 2006 Oct 4;26(40):10129-40
pubmed: 17021169
J Psychiatry Neurosci. 2015 May;40(3):151-61
pubmed: 25455349
Brain Res. 2020 Jan 15;1727:146587
pubmed: 31811838
J Biol Chem. 2001 Jun 15;276(24):21562-70
pubmed: 11279122
Cells. 2020 Sep 28;9(10):
pubmed: 32998477
J Neurosci Res. 2019 Feb;97(2):149-161
pubmed: 30345544
Neurobiol Dis. 2009 Mar;33(3):518-25
pubmed: 19166938
Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2432-7
pubmed: 12591950
J Neurosci. 2001 Mar 1;21(5):1501-9
pubmed: 11222640
Cell Death Dis. 2014 Jan 23;5:e1019
pubmed: 24457963
J Alzheimers Dis. 2018;63(2):665-674
pubmed: 29660941
Mol Neurodegener. 2013 Jan 14;8:2
pubmed: 23316765
J Neurochem. 2001 Jan;76(1):316-20
pubmed: 11146006